These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2286355)

  • 1. Factor X-activating procoagulant in normal and malignant breast tissue.
    el-Baruni K; Taylor I; Roath S; Francis JL
    Hematol Oncol; 1990; 8(6):323-32. PubMed ID: 2286355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor X-activating activity in normal and malignant colorectal tissue.
    Francis JL; el-Baruni K; Roath OS; Taylor I
    Thromb Res; 1988 Nov; 52(3):207-17. PubMed ID: 3194897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor X-activating activity in patients with colorectal carcinoma.
    Dover R; Goeting NL; Taylor I; Roath OS; Francis JL
    Br J Surg; 1987 Dec; 74(12):1122-4. PubMed ID: 3427359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procoagulant properties of benign and malignant prostatic tissue.
    Adamson AS; Francis JL; Witherow RO; Snell ME
    Br J Urol; 1994 Aug; 74(2):204-9. PubMed ID: 7522873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.
    Szczepański M; Bardadin K; Zawadzki J; Pypno W
    J Cancer Res Clin Oncol; 1988; 114(5):519-22. PubMed ID: 3182913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor X-activating activity from Guerin epithelioma.
    Mielicki W; Wierzbicki R
    Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
    Gordon SG; Franks JJ; Lewis BJ
    J Natl Cancer Inst; 1979 Apr; 62(4):773-6. PubMed ID: 285292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylmethylsulfonyl fluoride alters sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals.
    Pope CN; Chapman ML; Tanaka D; Padilla S
    Neurotoxicology; 1992; 13(2):355-64. PubMed ID: 1436755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
    Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
    Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of cancer procoagulant.
    Mielicki WP
    Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
    Francis JL; Carty N; Amirkhosravi M; Loizidou M; Cooper A; Taylor I
    Br J Cancer; 1992 Mar; 65(3):329-34. PubMed ID: 1558784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the inhibitory action of DFP and PMSF on histamine release from isolated rat mast cells [proceedings].
    Diamant B; Patkar SA
    Agents Actions; 1977 Mar; 7(1):110-1. PubMed ID: 67779
    [No Abstract]   [Full Text] [Related]  

  • 16. Clotting factor VII during pregnancy, delivery and puerperium.
    Dalaker K
    Br J Obstet Gynaecol; 1986 Jan; 93(1):17-21. PubMed ID: 3942701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteolytic procoagulant associated with malignant transformation.
    Gordon SG
    J Histochem Cytochem; 1981 Mar; 29(3A Suppl):457-63. PubMed ID: 7016982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer procoagulant in acute lymphoblastic leukemia.
    Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
    Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.
    Adamson AS; Luckert P; Pollard M; Snell ME; Amirkhosravi M; Francis JL
    Br J Cancer; 1994 Feb; 69(2):286-90. PubMed ID: 8297726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide.
    Slanina P; Falkeborn Y; Frech W; Cedergren A
    Food Chem Toxicol; 1984 May; 22(5):391-7. PubMed ID: 6539288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.